Literature DB >> 19587162

IL-1beta inhibits TGFbeta in the temporomandibular joint.

W H Lim1, J Toothman, J H Miller, R H Tallents, S M Brouxhon, M E Olschowka, S Kyrkanides.   

Abstract

Similarly to humans, healthy, wild-type mice develop osteoarthritis, including of the temporomandibular joint (TMJ), as a result of aging. Pro-inflammatory cytokines, such as IL-1beta, IL-6, and TNFalpha, are known to contribute to the development of osteoarthritis, whereas TGFbeta has been associated with articular regeneration. We hypothesized that a balance between IL-1beta and TGFbeta underlies the development of TMJ osteoarthritis, whereby IL-1beta signaling down-regulates TGFbeta expression as part of disease pathology. Our studies in wild-type mice, as well as the Col1-IL1beta(XAT) mouse model of osteoarthritis, demonstrated an inverse correlation between IL-1beta and TGFbeta expression in the TMJ. IL-1beta etiologically correlated with joint pathology, whereas TGFbeta expression associated with IL-1beta down-regulation and improvement of articular pathology. Better understanding of the underlying inflammatory processes during disease will potentially enable us to harness inflammation for orofacial tissue regeneration.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19587162      PMCID: PMC3317986          DOI: 10.1177/0022034509336823

Source DB:  PubMed          Journal:  J Dent Res        ISSN: 0022-0345            Impact factor:   6.116


  42 in total

1.  Matrix synthesis in mandibular condylar cartilage of aging mice.

Authors:  E Livne
Journal:  Osteoarthritis Cartilage       Date:  1994-09       Impact factor: 6.576

2.  Differential effects of aging on human chondrocyte responses to transforming growth factor beta: increased pyrophosphate production and decreased cell proliferation.

Authors:  F Rosen; G McCabe; J Quach; J Solan; R Terkeltaub; J E Seegmiller; M Lotz
Journal:  Arthritis Rheum       Date:  1997-07

3.  Transforming growth factor beta exerts opposite effects from interleukin-1 beta on cultured rabbit articular chondrocytes through reduction of interleukin-1 receptor expression.

Authors:  F Rédini; A Mauviel; S Pronost; G Loyau; J P Pujol
Journal:  Arthritis Rheum       Date:  1993-01

4.  TGFbeta1 and TGFbeta2 mRNA and protein expression in human bone samples.

Authors:  S Hering; E Isken; C Knabbe; J Janott; C Jost; A Pommer; G Muhr; H Schatz; A F Pfeiffer
Journal:  Exp Clin Endocrinol Diabetes       Date:  2001       Impact factor: 2.949

5.  Co-expression of interleukin-1beta and tumor necrosis factor alpha in synovial tissues and synovial fluids of temporomandibular joint with internal derangement: comparison with histological grading of synovial inflammation.

Authors:  Toshikazu Suzuki; Natsuki Segami; Masaaki Nishimura; Takayuki Nojima
Journal:  J Oral Pathol Med       Date:  2002-10       Impact factor: 4.253

Review 6.  Cytokines in osteoarthritis: mediators or markers of joint destruction?

Authors:  C I Westacott; M Sharif
Journal:  Semin Arthritis Rheum       Date:  1996-02       Impact factor: 5.532

7.  Osteoarthritis of the temporomandibular joint: a light microscopic and scanning electron microscopic study of the articular cartilage of the mandibular condyle.

Authors:  L G De Bont; G Boering; R S Liem; P Havinga
Journal:  J Oral Maxillofac Surg       Date:  1985-07       Impact factor: 1.895

8.  Stimulation of BMP-2 expression by pro-inflammatory cytokines IL-1 and TNF-alpha in normal and osteoarthritic chondrocytes.

Authors:  Naoshi Fukui; Yong Zhu; William J Maloney; John Clohisy; Linda J Sandell
Journal:  J Bone Joint Surg Am       Date:  2003       Impact factor: 5.284

9.  Amelioration of pain and histopathologic joint abnormalities in the Col1-IL-1beta(XAT) mouse model of arthritis by intraarticular induction of mu-opioid receptor into the temporomandibular joint.

Authors:  Stephanos Kyrkanides; Paolo M Fiorentino; Jen-nie H Miller; Yanjun Gan; Yu-Ching Lai; Solomon S Shaftel; J Edward Puzas; Maria G Piancino; M Kerry O'Banion; Ross H Tallents
Journal:  Arthritis Rheum       Date:  2007-06

10.  Reduced transforming growth factor-beta signaling in cartilage of old mice: role in impaired repair capacity.

Authors:  E N Blaney Davidson; A Scharstuhl; E L Vitters; P M van der Kraan; W B van den Berg
Journal:  Arthritis Res Ther       Date:  2005-09-30       Impact factor: 5.156

View more
  6 in total

1.  Integrin α1β1 differentially regulates cytokine-mediated responses in chondrocytes.

Authors:  R Parekh; M K Lorenzo; S Y Shin; A Pozzi; A L Clark
Journal:  Osteoarthritis Cartilage       Date:  2014-01-11       Impact factor: 6.576

2.  Rejuvenation of the inflammatory system stimulates fracture repair in aged mice.

Authors:  Zhiqing Xing; Chuanyong Lu; Diane Hu; Theodore Miclau; Ralph S Marcucio
Journal:  J Orthop Res       Date:  2010-08       Impact factor: 3.494

3.  Biglycan and fibromodulin have essential roles in regulating chondrogenesis and extracellular matrix turnover in temporomandibular joint osteoarthritis.

Authors:  Mildred C Embree; Tina M Kilts; Mitsuaki Ono; Colette A Inkson; Fatima Syed-Picard; Morten A Karsdal; Ake Oldberg; Yanming Bi; Marian F Young
Journal:  Am J Pathol       Date:  2009-12-24       Impact factor: 4.307

4.  IL-1β promotes TGF-β1 and IL-2 dependent Foxp3 expression in regulatory T cells.

Authors:  Balaji B Ganesh; Palash Bhattacharya; Anupama Gopisetty; Jianrong Sheng; Chenthamarakshan Vasu; Bellur S Prabhakar
Journal:  PLoS One       Date:  2011-07-11       Impact factor: 3.240

Review 5.  Osteoimmunology of Oral and Maxillofacial Diseases: Translational Applications Based on Biological Mechanisms.

Authors:  Carla Alvarez; Gustavo Monasterio; Franco Cavalla; Luis A Córdova; Marcela Hernández; Dominique Heymann; Gustavo P Garlet; Timo Sorsa; Pirjo Pärnänen; Hsi-Ming Lee; Lorne M Golub; Rolando Vernal; Alpdogan Kantarci
Journal:  Front Immunol       Date:  2019-07-18       Impact factor: 8.786

6.  Zoledronate promotes ECM degradation and apoptosis via Wnt/β-catenin.

Authors:  Jialing Xiao; Yali Li; Gang Cheng; Guochao Xu
Journal:  Open Med (Wars)       Date:  2022-04-18
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.